Curcumin May Lower Inflammation in COPD Patients
A small study found that a specific curcumin supplement reduced inflammatory markers in men with COPD over two months.
Updated on Oct. 21, 2026 in Asthma
Live Poll
Do you believe natural supplements like curcumin are effective for managing chronic health conditions?
A recent triple-blind randomized controlled trial found that a specific curcumin formulation reduced serum interleukin-17 levels in male patients with chronic obstructive pulmonary disease (COPD). The findings suggest a potential target for managing inflammation in those living with the condition.
Why it matters
COPD is characterized by persistent inflammation, and this trial explores whether a highly bioavailable form of curcumin can help suppress specific inflammatory markers like interleukin-17. This research aims to address the limitations of standard curcumin, which has historically suffered from poor absorption in the body.
This triple-blind randomized controlled trial of 68 male patients observed a 72% reduction in serum IL-17 in the curcumin group over 60 days, compared to an increase in the placebo group. The safety and efficacy of this approach remain under investigation in larger future trials.
The players
Lampung University
An academic institution in Indonesia where the lead investigators conducted this research on inflammation.
The details
Researchers utilized a specialized formulation combining turmeric oil and turmeric aqueous extract to overcome curcumin's naturally poor bioavailability. The participants received 1 gram of the supplement daily to investigate its potential role in suppressing neutrophilic inflammation, a common driver of airway damage in COPD. Levels of the inflammatory marker interleukin-17 were monitored throughout the study, showing a significant drop in the treatment arm compared to the placebo.
Timeline
• Researchers tracked progress starting at the 2-week mark, when IL-17 levels had already fallen to 42.34 pg/mL.
• Final measurements were taken after 2 months of daily supplementation.
• Trial results were formally presented on October 20, 2026, at the CHEST 2026 conference.
Health Landscape
This research contributes to the broader effort to identify adjunctive therapies for COPD that target specific inflammatory pathways. It highlights an evolving focus on improving the bioavailability of natural compounds to manage chronic respiratory inflammation.
While these results are promising, this formulation was tested only in a small group of men and requires further large-scale verification. Before adding any new supplements to your routine, it is essential to discuss potential interactions with your regular COPD treatments with your doctor.
The takeaway
This study indicates that specialized curcumin formulations may help lower inflammatory markers in men with COPD. As these findings are preliminary, patients should consult their pulmonologist before attempting to modify their existing care plan.
Further reading
Learn more about the latest research on inflammatory lung conditions in our Asthma section.
Source note: This article includes information reported by Hcplive.
Live Poll
Do you believe natural supplements like curcumin are effective for managing chronic health conditions?
